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ABSTRACT
Introduction Implementation data for digital unsupervised 
HIV self- testing (HIVST) are sparse. We evaluated the impact 
of an app- based, personalised, oral HIVST program offered by 
healthcare workers in Western Cape, South Africa.
Methods In a quasirandomised study (n=3095), we recruited 
consenting adults with undiagnosed HIV infection from 
township clinics. To the HIVST arm participants (n=1535), we 
offered a choice of an offsite (home, office or kiosk based), 
unsupervised digital HIVST program (n=962), or an onsite, 
clinic- based, supervised digital HIVST program (n=573) with 
24/7 linkages services.
With propensity score analyses, we compared outcomes 
(ie, linkages, new HIV infections and test referrals) with 
conventional HIV testing (ConvHT) arm participants (n=1560), 
recruited randomly from geographically separated clinics.
Results In both arms, participants were young (HIVST vs 
ConvHT) (mean age: 28.2 years vs 29.2 years), female (65.0% 
vs 76.0%) and had monthly income <3000 rand (80.8% vs 
75%).
Participants chose unsupervised HIVST (62.7%) versus 
supervised HIVST and reported multiple sex partners (10.88% 
vs 8.7%), exposure to sex workers (1.4% vs 0.2%) and fewer 
comorbidities (0.9% vs 1.9%). Almost all HIVST participants 
were linked (unsupervised HIVST (99.7%), supervised HIVST 
(99.8%) vs ConvHT (98.5%)) (adj RR 1.012; 95% CI 1.005 to 
1.018) with new HIV infections: overall HIVST (9%); supervised 
HIVST (10.9%) and unsupervised HIVST (7.6%) versus ConvHT 
(6.79%) (adj RR 1.305; 95% CI 1.023 to 1.665); test referrals: 
16.7% HIVST versus 3.1% ConvHT (adj RR 5.435; 95% CI 
4.024 to 7.340).
Conclusions Our flexible, personalised, app- based HIVST 
program, offered by healthcare workers, successfully linked 
almost all HIV self- testers, detected new infections and 




In 2016, the WHO recommended HIV self- 
testing (HIVST) for individuals living with 
undiagnosed HIV infection to know their 
serostatus.1 Performed with an approved self- 
test, HIVST offered preliminary screening 
test results, and laboratory- based confirma-
tory testing was deemed essential.1–4 Research 
Key questions
What is already known?
 ► The WHO has called for evidence on data for digital sup-
ports and use of community- based healthcare workers 
to improve services associated with HIV self- testing 
(HIVST).
 ► Data for HIVST with digital supports from Southern Africa, 
especially with app- based programs, remain sparse.
What are the new findings?
 ► Our healthcare workers offered a flexible, personalised 
program, with choice of venue and strategy, customised 
to preferences of participants.
 ► Participants who showed up to test in clinics were re-
cruited. We also documented the standard of care in the 
neighbouring clinics.
 ► Over an 18- month period, we linked all positive and 
negative unsupervised HIVST and supervised HIVST par-
ticipants to antiretroviral treatment initiation and preven-
tative care pathways. We detected new infections and 
referrals to self- test with the program.
What do the new findings imply?
 ► This quasirandomised transition- to- scale real- life study 
that mimicked a real- life implementation of HIVST with 
digital supports.
 ► Findings imply a possibility to link participants to care, 
with a trained corpus of healthcare workers, and a 24/7 
linkage service to counselling, prevention and treatment 
initiation through a personalised, anonymized, secure, 
app- based digital program.
 ► Findings are relevant for global stakeholders who wish to 
deploy such programs to young, digitally savvy popula-
tions in the region. It offers data to guide scale up of such 
strategies for HIV, related coinfections and COVID-19.
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evidence on HIVST has accumulated exponentially5–7 
with reported increases in self- test uptake,8–10 detection 
of new HIV infections, increases in test frequency and 
partner referrals.11–13
Recently, the WHO has called for evidence in HIVST in 
the following areas: (A) digital innovations, (B) community 
health workers and peer counsellors for operationalising 
linkages and (C) social network use for key populations.14 
Global data on scalable HIVST service delivery models with 
digital support tools that work in real- life settings remain 
sparse.15–17
With digital support tools, linkages to antiretroviral treat-
ment (ART) and prevention services (ie, pre- exposure 
prophylaxis, partner notification and medical circumci-
sion), tracking and surveillance are possible.18–20 With 
COVID-19 induced lockdowns and restrictions faced glob-
ally, the demand for digital tools has grown exponentially 
in countries.18–20 With an increasing availability of 4G/5G 
networks, together with an increase in ownership of smart-
phones/tablets in low and middle- income countries, there 
is an opportunity to scale digital solutions.
Global foundations and initiatives are looking for 
evidence to scale HIVST strategies/programs with digital 
support tools; yet for South Africa, data and evidence 
remain sparse. Furthermore, the impact of preferred 
choice of HIVST strategy, venue, and customized linkages, 
offered by health care workers and peer counsellors has 
never been explored.
To address these evidence gaps, we report an evaluation 
of a choice- based, personalised digital app/platform- based 
HIVST program, offered by healthcare workers and peer 
counsellors, in the township communities of Cape Town, 
South Africa.
Objectives
We set out to compare an offer of our oral HIVST program 
with digital supports, offered as supervised or unsupervised 
HIVST, to conventional HIV testing (ConvHT) (conven-
tional rapid and lab tests+onsite counsellor) on impact 
outcomes (ie, linkages, new infections and referrals to test).
Hypotheses
We conservatively hypothesised that the proportion of 
participants (self- testers) linked to post- test counselling and 
care (ie, ART initiation) and related prevention services 
(ie, medical circumcision, pre- exposure prophylaxis and 
partner notification) and the proportion of new infections 
detected in self testers will be comparable in both ConvHT 
and HIVST arms, whereas the proportion of self- test refer-
rals (within/to social networks) in the HIVST arm would 




Included participants were 18 years or older, of unknown 
HIV status at baseline (past 3 months), with access to an 
Android/iPhone smartphone or ability to use a tablet/
smartphone for HIVST. Excluded participants were either 
on antiretroviral therapy (ART), or with a confirmed HIV 
diagnosis, or a serious medical condition requiring hospi-
talisation.
Study design, recruitment setting and location
The evaluation was conducted in Cape Town, South 
Africa, between January 2017 and June 2018. A commu-
nity clinic- based quasirandomised trial study design was 
used to generate real- life field implementation data with 
an intention to scale the intervention on completion.
Convenience sampling was used to recruit participants. 
Members of the township population presenting to test 
for HIV by self- referral or referral by self- testers were 
recruited.
Patient and public involvement
Participants or the public were not involved in the design, 
or conduct, or reporting, or dissemination plans of our 
research.
Recruitment/sampling
We created a sampling frame of all clinics served by the 
University of Cape Town. Before study initiation, we geo- 
mapped all the districts in Western Cape and generated 
a random number sequence in STATA V.12. Within each 
district, from the sampling frame, we randomly sampled 
two geographically separated clinics to offer either HIVST 
or ConvHT for a total of six clinics in all.
Our study recruitment period was from January 2017 
to June 2018.
We recruited individuals who presented for HIV testing 
to the community outreach clinics and those who met the 
eligibility criteria. Study participants were encouraged 
to refer self- testing to their partners, friends and family 
within their close social networks. Individuals referred 
by self- testers that participated in the study were also 
recruited. Our clinic staff recruited participants during 
routine and drop- in visits.
For study promotions, community outreach by health-
care workers, word of mouth, handouts/flyers, demon-
stration videos in clinics, a Facebook page and radio/TV 
announcements were deployed.
Designing and developing the innovation
In 2009, in Canada, we first developed a web- based HIVST 
strategy using design thinking principles and evaluated 
a prototype for usability (HIVSmart!, McGill University, 
2013).21 Subsequently, we evaluated the strategy for feasi-
bility in South Africa22 and Canada.23 24 Funded by the 
Governments of Canada and South Africa, we expanded 
our strategy to a digital HIVST app- based program of care 
in 2015 (figure 1). We added the following features for 
personalisation: multilingual content in five languages 
(ie, Xhosa, Afrikaans, Zulu, English and French); a device 
agnostic, Android/iOS portable platform (ie, tablet, web, 
smart/mobile phone); added simplified video instruc-
tions for HIVST; self- test interpretation/capture with 
data storage; and a 24/7 preferred clinic based service 
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that offered pretest/post- test counselling/linkage service 
to treatment and prevention pathways, in their preferred 
language, to nearby clinics. The counselling and linkage 
service was offered 24/7 by trained healthcare workers 
and peer counsellors (ie, over phone calls, texts, chats, 
messages and face to face). We housed our program on 
a secure Health Insurance Portability and Accounta-
bility Act (HIPAA)- compliant cloud server and added a 
user- friendly dashboard and a global positioning system 
clinic locator, which was useful to both patients and 
providers.22 23
HIVST arm
Our intervention consisted of our innovative digital 
HIVST program together with an oral HIV self- test 
(OraQuick advance HIV-1/2, OraSure Technologies Inc, 
USA). Our mobile app was downloaded onto the partic-
ipant’s phone or tablet (using QR codes). Participants 
were provided a Wi- Fi access card for connectivity.
From each participant, the research nurse obtained 
informed consent, explained the study procedure, 
performed standard per clinic protocols (rapid tests 
and reference standard testing for the labs) to provide 
consistent reference standard data and collected data on 
sociodemographic and test experience.
Delivery of the intervention
We offered a choice of two strategies and associated 
venues to self- test, together with customised linkages to 
preferred clinics for ART initiation and follow- up chosen 
by participants. No financial incentives and no phones 
were offered to study participants. Only Wi- Fi access 
cards for connectivity were provided to make it easy for 
the participants to communicate with the healthcare 
workers through the app via text messages/calls. The 
phones belonged to the participants. Research staff who 
did not own phones were provided with smartphones and 
a Wi- Fi access card for the entire duration of the study for 
communication purposes only.
The procedures for each HIVST option to test were as 
follows:
1. Supervised digital HIVST at the clinic: participants 
performed HIVST in the presence of a counsellor or 
healthcare worker. For this option, participants were 
provided a tablet with the downloaded app, an oral 
self- test and a Wi- Fi access card to call counsellors. 
Figure 1 The HIVSmart! app- based digital program of care operated by healthcare workers and peer counsellors in Cape 
Town, South Africa.
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Participants were ushered to a private space set up in 
the clinic to perform the self- test. After self- test was 
conducted, participants could drop their self- test in a 
drop box outside the clinic. Total duration of interven-
tion was 1.5 hours (including orientation and testing). 
The tablet was housed in the clinic and was secured 
with a lock to prevent it from being taken home by 
anyone. Tablets were collected from the clinic at the 
end of the day and stored in a locked drawer in the 
offices of the principal investigator.
2. Unsupervised digital HIVST at a venue of their choice: 
the research nurse offered participants the option to 
conduct their self- tests unsupervised anywhere: at 
home, at their office or workspace or in private space 
(kiosk). The participants were provided with an oral 
self- test, a QR code and a Wi- Fi access card to call 
counsellors. Orientation time of 30 min, and unsu-
pervised test program of 1 hour, for a total duration 
of 1.5 hours.
The phones belonged to the participants and were not 
provided to the participants. Participants were asked 
to download the QR code in the presence of the coun-
sellor to check if the app was working. Once the app 
opened up, the participants were allowed to leave. 
Participants who were confident of testing by them-
selves chose the home/office option, and participants 
who lacked safe space to test at home or office chose to 
test at the kiosk. Participants were requested to drop 
the test kits back at the clinic in the drop off box, or 
bring it with them when they came back to the coun-
sellor for care.
To arrange for linkages to counselling, disease staging 
or ART initiation in test positives and prevention services 
in test negatives, the healthcare workers/peer coun-
sellors recorded participant’s language preferences, 
preferred mode of follow- up communication (chat, SMS, 
phone call and face to face) and their preferred clinic 
location (UCT vs non- UCT). This helped the healthcare 
workers customise their service to the choice, preference 
and lifestyle of participants.
ConvHT arm
ConvHT testing (standard of care standard rapid and 
lab tests) was offered in comparator clinics with onsite 
counsellors; duration was 1.5–2 hours with 3–4 hours of 
waiting time in clinics. The research nurses explained 
the study procedure to consenting participants, obtained 
informed consent and performed ConvHT (blood- based 
rapid tests and sample collection for reference standard), 
followed by data collection for sociodemographic varia-
bles and test experience. Participants were asked to refer 
their partners and friends and family to test for HIV at 
these clinics. Linkage and counselling service followed 
the model used for the ConvHT conducted in two steps. 
The first step in linkage seeking is post- test counselling 
and sharing of lab confirmed test result. This is followed 
by blood draw for disease staging of lab confirmed test 
positives and risk reduction counselling and triage 
to prevention services (ie, medical circumcision, pre- 
exposure prophylaxis and partner notification) for lab 
confirmed test negatives. The second step was ART initia-
tion at the clinic based on all lab results for test positives.
Outcomes
To evaluate the impact on the primary outcome, linkages 
to counselling, ART initiation and prevention services, we 
documented comparative linkage data from the ConvHT 
arm.
Linkage was defined in two ways:
1. Linkage to counselling, a proportion, was computed 
by documenting numerator/denominator. Numerator 
was compiuted as the number of both self- test positive 
and self- test negative participants who communicated 
and showed up for face- to- face post- test counselling, 
receipt of lab- confirmed test results, followed by dis-
ease staging of lab confirmed test positives, or triage 
to prevention services for lab confirmed test negatives. 
Denominator was defined as the total number of con-
senting participants who sought self testing.
2. Linkages to care was defined as the proportion of new-
ly identified participants linked to clinics for ART ini-
tiation (numerator) over total number of test positives 
identified in the study (denominator).
Proportion of linkages in each arm were documented, 
and comparisons were reported with risk ratio (RR) and 
associated 95% CIs.
For the HIVST arm, we recorded receipt of linkage 
services through the application; when a participant 
called for counselling, a phone call or virtual chat 
occurred, followed by a face- to- face meeting for services. 
Linkages to treatment for positives in preferred clinics 
were confirmed by date and corroborated with record of 
receipt of ART from clinic rosters by healthcare workers. 
Similarly, linkages to prevention services for test negatives 
were confirmed and corroborated with clinic records 
maintained by healthcare workers.
To evaluate the impact on the secondary outcome, 
detection of new infections, we compared and documented 
the proportion of newly identified participants as test 
positives in both arms. Test positives/negatives were 
confirmed by lab- confirmed results and test protocols. 
For both arms, we calculated the total number of new 
infections detected and staged (numerator) over the 
total number of individuals that sought testing (denom-
inator). To compare new infections, we considered the 
test results (against a reference standard of rapid tests 
and lab- confirmed tests) separately, and computed RR 
(95% CI).
To evaluate the impact on tertiary outcome, referrals to 
HIVST, separately for each arm (HIVST and ConvHT), 
we computed the total number of referrals to test made 
by a self- tester (phone- based and word- of- mouth refer-
rals) to someone in their social network (ie, partners, 
spouses, friends, family and community members). Next, 
for each arm, we compared the differences in estimates 
from the end of the study to baseline. Referrals were 
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documented by our research nurses who explained the 
choices of strategy or venues to test and inquired about 
their reasons and motivations for referrals. Referrals 
were not linked to primary self- tester to avoid a breach 
of confidentiality. Proportions were compared, and RRs 
(95% CI) were computed.
To document choice, we computed the proportions by 
calculating the total number of consenting HIVST partic-
ipants (denominator). We calculated HIVST participants 
who chose either strategy, supervised HIVST(one venue: 
clinic based), versus, unsupervised HIVST (three venues: 
home, office/prviate space and kiosk) for the numerator.
Sample size
Assuming an equivalence margin of 10%, success propor-
tion for linkage of 85% for HIVST arm and 90% for the 
conventional testing arm (alpha 5%; power of 95%), a 
sample size of 2262 participants (1131 in each arm) was 
deemed sufficient for our linkage estimations. Assuming 
an attrition rate of 10%, sample size of 1500 per cohort 
was estimated to be adequate to detect comparable link-
ages and new infections between HIVST and ConvHT 
and to detect a conservative twofold increase in referral 
in the HIVST cohort compared with ConvHT cohort, 
with a CI±10%.
Assignment method
The unit of assignment was the individual participant. 
Although our participants, investigators and staff were 
open (unblinded) to the intervention, outcome assessors 
(statisticians) were blinded to the intervention assign-
ment. Assignments were revealed to them at the end of 
their analyses. Assignment was restricted to clinics served 
by University of Cape Town.
Data sources, collection and measurement
For deidentification of each participant, a unique study 
ID number was created. It identified the site, the town-
ship clinic and the program (HIVST or ConvHT). Like-
wise, each self- test referral was coded by a reference 
number that identified the site, the township clinic and 
the program, self- reported by the study participant and 
recorded.
For both arms, we collected deidentified, encrypted, 
digital data on the app linked reference standard labora-
tory test data. For the ConvHT arm, baseline characteris-
tics (table 1) data were collected using digital case report 
forms with anonymised data on exposure, outcome and 
confounders. Laboratory data collected on tablets were 
supplemented by data from HIV registers/folders.
For the HIVST arm, anonymised data on exposure, 
outcome, confounders, laboratory data, review of HIV 
registers, encrypted data on the app and the server were 
similarly collected. Access to the HIPAA- compliant plat-
form was granted only to the two principal investigators 
involved in the study. Each day, data from the app were 
corroborated with lab data and clinic data. Access to 
recruiting staff was restricted to data entry only.
A regular oversight and monitoring of recruitment 
was possible with a dashboard. Daily record of numbers 
improved data quality and provided a snapshot to the key 
personnel involved in the study. Data on ART clinic initia-
tion and lab results were corroborated with clinic rosters. 
Some participants preferred to link to clinics outside 
the University of Cape Town (UCT) system. To allow for 
this, permission was sought from the city to collect data 
from non- UCT clinics by study staff. All self- tests were 
confirmed by rapid tests and laboratory tests as per clinic 
protocols.
Statistical methods
A descriptive analysis on characteristics of all study partic-
ipants was performed. For the continuous covariates, we 
reported mean (SD), and for categorical covariates, we 
reported % in each category. We replaced missing covar-
iate values by the most frequent category (categorical 
variables) or the median (continuous variables).
We considered outcome metrics (ie, linkages, new 
infections and referrals) as binary and defined success 
and failure appropriately. For each outcome, we 
compared the proportion of success between the HIVST 
and ConvHT arms. We performed the statistical z- test to 
compare two proportions, and we reported the RR and 
95% CI for our outcomes.
An RR >1 indicated that the HIVST arms were favour-
able (linkage, new infections and higher referral), while 
an RR <1 indicated that the ConvHT arm was favourable.
To control for confounding at baseline (to reduce selec-
tion bias), we performed a propensity- matched analysis 
of outcomes. Variables for the propensity model (ie, age, 
gender, Socio- economic status (SES), work status, sexual 
history and comorbidities) were decided a priori based 
on their significance and their impact on participant’s 
choice and preference. A nearest- neighbour matching 
criterion was used to identify comparable subjects in 
each cohort. Following the identification of the matched 
cohort, we estimated the RR and CI for each of the 
outcomes as mentioned by Austin25 and performed our 
Statistical analyses in R (V.3.3.0).
RESULTS
Demographics and flow
A total of 3137 participants were enrolled, of which 33 
in the self- testing arm and nine in the conventional arm 
opted out (reasons are documented in figure 2).
Of the 3095 participants, 1535 participants in the 
HIVST arm and 1560 participants in the ConvHT were 
recruited, respectively. A majority of participants in the 
HIVST arm (n=962, 62.7%) chose unsupervised HIVST 
over supervised HIVST (n=573, 37.3%).
Sociodemographic data on participants in HIVST 
versus ConvHT arm demonstrates that participants in 
both arms were young (mean age: 28.2 years vs 29.2 
years), female (65.0% vs 76.0%) and poor <3000 rand 
(US$253) (80.8% vs 75.0%).
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Age, mean (SD) 28.23 (8.83) 29.18 (8.56) − 0.95 (−1.56 to 0.34)
NA=missing (n (%)) 0 (0.00) 1 (0.06) −0.0006 (−0.0018 to 0.0006)
Gender
(n (%) male)
541 (35.24) 378 (24.23) 0.11 (0.08 to 0.14) *
NA=missing 0 (0.00) 1 (0.06) −0.0006 (−0.0018 to 0.0006)
Education (n (%))
0=no schooling OR primary school 114 (7.43) 100 (6.41) 0.01 (−0.01 to 0.03)
1=high school OR more advanced 1420 (92.51) 1460 (93.59) −0.01 (−0.03 to 0.01)
NA=missing 1 (0.07 %) 0 (0.00 %) 0.0007 (−0.0006 to 0.0020)
Work situations (n (%))
0=employed (full time) 337 (21.95) 567 (36.35) −0.14 (−0.18 to 0.11)*
1=employed (part time) 207 (13.49) 177 (11.35) 0.02 (−0.002 to 0.044)
2=not employed 916 (59.67) 812 (52.05) 0.07 (0.04 to 0.11)*
3=retired 12 (0.78) 4 (0.26) 0.005 (0.0001 to 0.0103)*
NA=missing 63 (4.10) 0 (0.00) 0.041 (0.031 to 0.051)*
Monthly income (n (%))
0 =<3000 rand 1190 (77.52 %) 1167 (74.81) 0.03 (−0.002 to 0.06)
1=3000–6000 rand 153 (9.97) 304 (19.49) −0.09 (−0.12 to 0.07)*
2=6000–9000 rand 61 (3.97) 46 (2.95) 0.01 (−0.003 to 0.023)
3 =>9000rRand 68 (4.43) 40 (2.56) 0.02 (0.01 to 0.03)*
NA=missing 63 (4.10) 3 (0.19) 0.04 (0.03 to 0.05)*
Source of income (n (%))
0=employed 531 (34.59) 742 (47.52) −0.13 (−0.16 to 0.09)*
1=family or friends 947 (61.69) 766 (49.10) 0.13 (0.09 to 0.16)*
2=grant 47 (3.06) 46 (2.95) 0.001 (−0.01 to 0.01)
3=pension 9 (0.59) 6 (0.38) 0.002 (−0.003 to 0.006)
NA=missing 1 (0.07) 0 (0.00) 0.007 (−0.0006 to 0.0020)
Previous HIV test (n (%))
0=first- ever HIV test 75 (4.89) 58 (3.72) 0.01 (−0.002 to 0.026)
1=repeat HIV test (last test less than 
1 year ago)
915 (59.61) 1021 (65.45) −0.06 (−0.09 to 0.02)*
2=repeat HIV test (last test more 
than 1 year ago)
544 (35.44) 481 (30.83) 0.05 (0.01 to 0.08)*
NA=missing 1 (0.07) 0 (0.00) 0.0007 (−0.0006 to 0.0020)
Current partner your husband or 
wife?
(n (%) yes)
429 (27.95) 432 (27.69) 0.002 (−0.03 to 0.03)
NA=missing 69 (4.50) 12 (0.77) 0.04 (0.03 to 0.05)*
Are you sexually active? (n (%) 
yes)
1223 (79.67) 1481 (94.94) −0.15 (−0.17 to 0.13)*
NA=missing 74 (4.82) 0 (0.00) 0.05 (0.04 to 0.06)*
In the past 6 months, sex with 
multiple partners (n (%) yes)
167 (10.88) 136 (8.72 0.02 (0.001 to 0.042)*
NA=missing 81 (5.28) 0 (0.00) 0.05 (0.04 to 0.06)*
In the past 6 months, sex with a 
sex worker (n (%) yes)
21 (1.37) 3 (0.19) 0.01 (0.005 to 0.018)*
NA=missing (%) 81 (5.28) 0 (0.00) 0.05 (0.04 to 0.06)
Continued
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Participants in the HIVST arm versus ConvHT arm 
reported significant differences in the following variables: 
sex with multiple partners (11.5% vs 8.7%), exposure to 
sex workers (1.4% vs 0.2%), less sexual actiivty (79.6% vs 
94.9%), with repeat HIV test more than a year (35.4% vs 
30.8%), repeat HIV test less than a year (59.6% vs 64.5%) 
and HIVST participants versus ConvHT arm participants 
were also relatively healthier with fewer comorbidities 
(diabetes: 0.9% vs 1.9%; hypertension: 2.9% vs 8.2% and 
asthma: 2.35% vs 5.19%). More men attempted to know 
their status through HIVST versus ConvHT (35.24% vs 
24. 23%).
Please refer to table 1 for baseline sociodemographic 
characteristics.
Outcomes
Compared with ConvHT (98.5%), in the HIVST arm, our 
primary linkage outcome to counselling and care was high 
at 99.7% (break up: unsupervised HIVST arm: 99.8%; 
supervised HIVST arm at 99.3%) (unadjusted RR: 1.012; 
95% CI 1.005 to 1.018; propensity- adjusted RR: 1.011; 
95% CI 1.005 to 1.018). Our secondary linkage outcome 
for ART initiation for HIV test positives and prevention 
pathways for HIV negatives was ((overall digital HIVST: 
98.1%; supervised HIVST: 95.7%; unsupervised HIVST: 
99.3%)) and comparable with ConvHT: 98.5%.
At 1 month, we documented the losses to follow- up 
in each arm. In the HIVST arm, we had 38 participants 
(break up: 23 supervised, 15 unsupervised arm) versus 23 
participants in the ConvHT arm.
Regarding new infections, compared with ConvHT 
arm at 106/1560 (6.79%), we detected a slightly overall 
higher proportion (9%) in the HIVST arm (break up: 
unsupervised HIVST at 73/962 (7.6%) and supervised 
HIVST at 63/573 (10.9%)) (RR: 1.305; 95% CI 1.023 to 
1.665). Propensity- adjusted analysis showed marginally 
better performance in the HIVST arm versus ConvHT 
(RR: 1.295; 95% CI 1.011 to 1.665).
As for referrals to self- test within their social network 
(ie, partners, family and friends), it was proportion-
ally higher in the HIVST arm (16.7%) versus ConvHT 
arm (3.1%) (RR: 5.435; 95% CI 4.024 to 7.340). The 
propensity- adjusted analysis preserved the RR (adjusted 
RR: 5.391; 95% CI 3.992 to 7.281).
Regarding choice, an overwhelming majority (n=962 
(62.67%)) chose the unsupervised HIVST strategy, while 
a few (n=573 (37%)) chose supervised HIVST. Partic-
ipants were 1.70 times more likely to choose the unsu-
pervised HIVST over supervised HIVST, reflecting the 
popularity of our digital unsupervised HIVST strategy. 
Among choice of venue to test unsupervised, homes and 
kiosks were popular followed by offices/workspaces.
Please refer to table 2A,B for analyses, respectively.
DISCUSSION
To the participants, we offered a personalised, choice- 
based HIVST program with digital support tools, in a 
real- life implementation study design, and compared 
impact outcomes in HIVST versus ConvHT arms.
First, many participants in the HIVST arm (n=962 
participants, 62.7%) chose unsupervised over supervised 
HIVST strategy, reflecting the need for autonomy, privacy 
and convenience to self- test. Compared with ConvHT 
(98.5%), our linkage proportions for counselling for 
HIVST were at (99.7% overall). Break up of linkage 
metrics for HIVST: unsupervised digital HIVST (99.8%), 
supervised digital HIVST (99.3%). Our linkage propor-
tions for ART initiation in HIVST arm were comparable 
with ConvHT, reflecting the fact that our participants 
preferred the customised program offered by our health-
care workers.
Operationalising linkages has been a huge challenge 
in HIVST. Globally, linkage data for digital unsupervised 
HIVST with app- based programs are sparse. Linkage data 
for HIVST (without a digital component) varies between 
51% and 81%1 and has been reported from many coun-
tries: Thailand,26 China,27 28 Vietnam,29 Singapore,30 the 
Americas (Brazil,31 USA32–34 and Canada),23 24 Australia35 
and Europe (Spain).36 We believe that our customised, 
unincentivised, 24/7 digital program offered by our 








In the past 6 months, sex with an 
HIV- infected partner (n (%) yes)
42 (2.74) 35 (2.24) 0.005 (−0.006 to 0.015)
NA=missing 81 (5.28) 0 (0.00) 0.05 (0.04 to 0.06)
Have you ever been diagnosed 
with:
Tuberculosis (n (%) yes) * 121 (7.88) 126 (8.08) −0.002 (−0.02 to 0.02)
Other lung infection (n (%) yes) * 6 (0.39) 5 (0.32) 0.0007 (−0.003 to 0.005)
Diabetes (n (%) yes) * 14 (0.91) 29 (1.86) −0.009 (−0.0177 to 0.0012)*
Hypertension (n (%) yes) * 46 (3.00) 128 (8.21) −0.05 (−0.07 to 0.04)*
Asthma (n (%) yes) * 36 (2.35) 81 (5.19) −0.04 (−0.05 to 0.02)*
*No missing data in both arms.
Table 1 Continued
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venue to test, contributed to the success of our strategy.37 
HIVST strategy was popular, but unsupervised HIVST 
appealed to the participants that wanted to exercise 
privacy, autonomy and independence to test anywhere. 
Although homes, offices were popular venues to self- test, 
those participants who did not find homes/offices to be 
safe/comfortable preferred kiosks. Exploration of choice 
of strategy and venue in the context of this study has been 
examined in great detail in related recently published 
qualitative research from this project.38 39
Retention in care was also maintained throughout the 
study period through digital communication. This was 
not entirely surprising, for we found similar retention in 
care estimates with our AideSmart! Multiplex app- based 
program for coinfections for pregnant women in rural 
India.40 Retention in care in participants was possible 
Figure 2 Flow diagram of participants through the HIVST and ConvHT arms. ConvHT, conventional HIV testing; HIVST, HIV 
self- testing.
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without incentives because of a personalised service avail-
able 24/7 that catered to their lifestyle and accommo-
dated their choice and preferences that further enabled 
its success.
Second, although we detected a modest increase in 
new infections in the HIVST arm versus ConvHT arm 
(RR: 1.305; 95% CI 1.023 to 1.665), we detected many 
new HIV infections in both supervised and unsuper-
vised HIVST arms; this finding concurs with cumulative 
evidence in HIVST.1 HIV incidence is explained by the 
popularity of the strategy in young populations. The HIV 
incidence was high in young women and their referrals. 
Perhaps, there is a need for targeted, digital strategies to 
engage these young digitally savvy populations.41
Third, we extended referrals to partners, friends and 
family within their social network, including those in 
need of HIV testing and those living with undiagnosed 
HIV infection and those that were not keen to test in 
conventional clinics.42 43 With that, we found a high 
proportion of referrals for HIVST. This finding is in line 
with WHO recommendations for HIVST. Secondary 
distribution of self- tests to partners has been successful 
in HIVST.44 Incidentally, our self- testers were predom-
inantly young women, but our referrals were predomi-
nantly men. Rapid information sharing by women to men 
was possible through our digital HIVST app that actively 
engaged young men.45 We concur that women could be 
the change agents for HIVST- by encouraging men within 
their social network to self- test, with a digital program. 
they can expedite progress towards UNAIDS targets. Our 
finding is aligned with HIVST studies43 46 47 and supports 
current WHO recommendations.
A few elements of our HIVST program have contrib-
uted to its success. These are: (A) deployment of a 
complete app- based program with digital supports, (B) 
offering a choice of strategy, a choice of venue to self- 
test and a choice to link participants to their preferred 
clinics for ART and prevention pathways, (C) provision of 
customised communication in the participant’s language, 
together with a choice of communication modalities (ie, 
text, calls, chat, followed by face to face), encouraged a 
bidirectional exchange impacting participant engage-
ment; (D) continued presence of our team of healthcare 
workers with a 24/7 service that included facilitating 
counselling, linkage to ART initiation at the nearest 
preferred clinic, facilitating follow- up and linkages to 
prevention services; and lastly (E) task shifting of coun-
sellors and healthcare workers, from performing primary 
screening in clinics to optimising linkages.46
Strengths
Our study strengths lay in its novelty, its digital program, 
its large sample size, representative digitally savvy young 
populations and flexible real- life implementation study 
design. A quasirandomised study design offered the flex-
ibility to understand choice of strategy, venue to test and 
customisation of counselling and linkage services based 
on self- tester’s preference and comfort level with tech-
nology. It was not possible to explore choice nor offer 
flexibility, within a randomised clinical trial framework. 
Furthermore, many such flexible designs are now being 
recommended for digital initiatives.48 We have conducted 
extensive qualitative research to explore the role of 
choice, flexibility and preferences, and customisation 
in detail.38 39 We are also completing a cost- effectiveness 
analysis.49
Limitations
Our data are comparable, as confirmed by negligible 
baseline differences (balance) in the participants’ demo-
graphics minimising sampling bias. A random selection of 
study and comparator sites in the design stage minimised 
selection bias. A complete reporting of all deidentified 
outcomes and blinding our statisticians to the interven-
tion assignment minimised detection bias. Propensity- 
adjusted modelling minimised confounding at baseline. 
Propensity scores do not account for latent characteris-
tics, which could not be ruled out. Social desirability bias 
could not be ruled out. Despite these limitations, our 
analyses showed similar outcomes, and matched results 
in both arms favoured a digital HIVST over ConvHT.
Inherent risks of self- testing without an app- based 
guided program are namely: (A) failure of self- test as 
described in the self- test brochures, (B) failure to record 
and log their self- test result accurately, (C) failure to call 
for counselling when in need and (D) failure to seek 
linkage to ART care and initiation in nearest clinics. 
These risks exist for an unsupported program and cannot 
be discounted. Although app- based programs and web 
programs if adequately supported and maintained can 
minimise these risks, but they cannot necessarily elimi-
nate them.
Generalisability
Our findings may be generalisable to young popu-
lations from South Africa and similar digitally savvy 
Table 2 Multivariate analyses and propensity score 
matched analyses.
A: multivariate analyses; adjusted risk ratio (RR) and 
risk differences with 95% CI for outcomes of interest; 
reference group conventional arm
  RR 95% CI
Linkages 1.012 1.005 to 1.018
New infections 1.305 1.023 to 1.665
Referral 5.435 4.024 to 7.340
B: propensity- matched analyses; adjusted RR with 




Linkage 1.011 1.005 to 1.018
New infections 1.295 1.011 to 1.660
Referral 5.391 3.992 to 7.281
10 Pai N, et al. BMJ Global Health 2021;6:e006032. doi:10.1136/bmjgh-2021-006032
BMJ Global Health
populations who can navigate care and counselling 
proactively, using an app- based program, guided by 
healthcare workers.
Our HIVST strategy is applicable in settings and in 
contexts where a committed team of counsellors is willing 
to work with the participants to customise their preferred 
choice of venue, language and linkage to clinics. Our 
study was restricted to Western Cape, which had a greater 
penetration of internet connectivity. Our recruiting 
clinics were served by the University of Cape Town, which 
has a formidable reputation in the city. The program was 
successful with a team of healthcare workers who were 
familiar with the patient populations they served and 
were able to navigate the healthcare systems with the 
study participants.
Some additional points of interest for implementers 
are highlighted below.
First, although we did not incentivise our program, we 
provided a flexible, choice- driven customised service that 
was greatly appreciated by participants. Flexibility and 
choice of venue and digital supports increased and main-
tained a continued engagement with our study partic-
ipants. Second, this program will only work in settings 
where digital or Wi- Fi connectivity are uninterrupted, 
where participants are digitally savvy and can navigate an 
app- based service proactively. For those participants who 
had difficulty navigating their phones, we offered a choice 
of supervised strategy in clinics or kiosk based unsuper-
vised HIVST strategy offered on tablets. Third, imple-
mentation challenges that were faced by us included the 
use of a protected HIPAA- compliant server that ran into 
firewall issues initially but took a month to resolve these 
issues. HIPAA- compliant servers are expensive but ensure 
data privacy and security. Fourth, some participants 
did not have the best Android phones (version five or 
higher), and they could not run the entire program on 
their phones due to bandwidth and storage issues, so they 
opted for the supervised HIVST in clinics or the kiosk 
based unsupervised HIVST. Fifth, mobilising ART initia-
tion outside of UCT clinics required permission from the 
city. Sixth, the inherent sampling and social desirability 
bias in the study could impact generalisability of study 
findings. Those participants who desired to self- test using 
phones and apps consented to the study. Further explo-
ration of these biases is needed to better customise these 
programs for young populations. Seventh, the continuous 
presence of UCT clinicians for ART initiation and care 
and presence of UCT trained counsellors and nurses for 
counselling and support for the duration of the project 
facilitated care. Lastly, mobilising and addressing the 
scepticism of some of our counsellors who were hesitant 
initially to embrace technology was an early challenge. 
The counsellors feared losing their jobs. However, as the 
study progressed, they engaged better with technology 
and found its relevance and its reach in serving popula-
tions they cared for and with speed and efficiency. After 
a few months, these counsellors became the champions 
of our program. Thus, by creating champions, the study 
generated clinical and public health impact data of rele-
vance and generated social impact.
Implications
In 2021, in the setting of COVID-19 infection, recurrent 
lockdowns and COVID-19 variant induced epidemics are 
making it difficult to offer routine screening for HIV in 
public settings. Now, more than ever, there is an increased 
demand for HIVST with digital supports and related 
demand for increased screening for sexually transmitted 
and blood- borne infections. HIVST with digital support 
tools can pave the way for digital self- testing/self- sampling 
options for related screening initiatives for hepatitis C, 
COVID-19, Human Papillomavirus (HPV) and Chlamy-
diae Trachomatis /Neisseria Gonorrheae (CT/GC).
While barriers like smartphone ownership, digital 
literacy, access to Wi- Fi and connectivity (digital divide) 
impede expanded access, they also offer opportunities 
to think of out- of- the- box ways to improve access. These 
include setting up public/private partnerships that offer 
a limited time ownership of smartphones or free Wi- Fi 
connectivity for a clinical or health service of a limited 
duration. Furthermore, flexible self- testing programs 
with digital supports should consider an affiliation with a 
credible organisation that offers a clinical service that is 
well regarded by the communities. Digital supports could 
be offered through flexible venues: online (through plat-
forms), or through apps (smartphones), for homes or 
office use, or through kiosks in outreach clinics, malls, 
public and private pharmacies, or by non- government 
organisation- based outreach clinics, mobile vans or 
vending machines.46
Digital programs could be made available for open 
access for low- income countries and available for scale 
up in fast- track cities, through government support 
and smart public private partnerships.22 50 Funded by 
the Canadian Institutes of Health Research (CIHR), in 
the coming years, we plan to expand our digital HIVST 
strategy for self- testing in key populations across Cana-
dian provinces.51
CONCLUSION
Our choice- based, customised, self- tester centred, flex-
ible digital HIVST program, offered by a dedicated 
team of healthcare workers and counsellors, successfully 
linked almost all self- testers to treatment and care. It 
detected new infections, reported an increase in referrals 
to HIVST and maintained engagement of participants 
for the duration of the project.
HIVST with digital support tools like smart apps and 
web platforms offers an untapped potential to fast track 
our progress towards UNAIDS targets for HIV elimina-
tion in many countries. Our findings find relevance in 
the planning and scaling of many self- testing and similar 
digital health initiatives worldwide.
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